Clinical trial NCT05210751: Dual Task in Female Patients With Fibromyalgia
Official title: Investigation of the Relationship Between Dual Task With Physical and Psychosocial Factors in Female Patients With Fibromyalgia
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Fibromyalgia
Dual Task
Physical Function
Psychosocial Problem
Keywords: Fibromyalgia
dual task
physical function
Psychosocial Problem
Lead sponsor: Izmir Katip Celebi University
Sponsor class: OTHER
First posted: 2022-01-27
Enrollment: 80
Sex: FEMALE
Minimum age (years): 30
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: - Women Women Patients aged 30-75 years diagnosed with fibromyalgia by a rheumatologist according to criteria set by the American College of Rheumatology and healthy control group

Brief summary: The aim of our study is to examine the relationship between dual task and physical and psychosocial factors in female patients with fibromyalgia.

We will perform Dual Task Test, 6 min Walking Test, the Baecke Habitual Physical Activity Questionnaire, Multidimensional Fatigue Inventory-20, Tracking Test, General Self-Efficacy Scale the Toronto Alexithymia Scale, the Revised FM Impact Questionnaire, the Social Support Scale.

Detailed description: Dual-tasking is a procedure that requires an individual to perform two tasks simultaneously to compare performance with single-task conditions, and the characteristics associated with dual-task performance in patients with fibromyalgia are unclear. Therefore, in our study, we focused on examining the relationship between dual task and physical and psychosocial factors.

Patients with a diagnosis of fibromyalgia will be included in our study.

Dual-task assessment of women with FM is with the "Dual Task Test", aerobic capacity with the "6 min Walking Test", physical activity level with the "Baecke Habitual Physical Activity Questionnaire", fatigue levels with the "Multidimensional Fatigue Inventory-20", cognitive levels With the "Tracking Test", self-efficacy levels with the "General Self-Efficacy Scale", alexithymia levels with the "Toronto Alexithymia Scale", quality of life with the "Revised FM Impact Questionnaire", motivation levels with the "Social Support Scale" will be evaluated .

Eligibility criteria: Inclusion Criteria:

* Women aged 30-75 years
* Patients diagnosed with fibromyalgia by a rheumatologist according to criteria set by the American College of Rheumatology
* Patients who can communicate effectively with study staff.
* Patients who have read, understood and signed the informed consent form

Exclusion Criteria:

* Those who are pregnant
* Participants who could not sit and stand in a chair even once, or climb stairs unaided
* Other rheumatic diseases and other severe somatic or psychiatric disorders such as cancer, severe coronary disease, or other serious somatic or psychiatric disorders such as schizophrenia

Primary outcomes:
measure: Dual Task Assessment
timeFrame: 5 minutes
Secondary outcomes:
measure: Functional capacity
timeFrame: 15 minutes
measure: Physical Activity Assessment
timeFrame: 15 minutes
measure: Fatigue Assessment
timeFrame: 10 minutes
measure: Self-Efficacy Assessment
timeFrame: 10 minutes
measure: Alexithymia Assessment
timeFrame: 15 minutes
measure: Fibromyalgia Impact Assessment
timeFrame: 20 minutes
measure: Assessment of Social Support
timeFrame: 20 minutes
measure: Cognitive Assessment
timeFrame: 20 minutes
Other outcomes:
Locations:
city: İzmir
country: Turkey
facility: İlknur Naz Gürşan
Study officials:
References: